SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3,998.81 |
| Enterprise Value ($M) | 3,773.14 |
| Book Value ($M) | 1,939.66 |
| Book Value / Share | 22.73 |
| Price / Book | 2.06 |
| NCAV ($M) | 1,627.42 |
| NCAV / Share | 19.07 |
| Price / NCAV | 2.46 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.11 |
| Return on Assets (ROA) | -0.11 |
| Return on Equity (ROE) | -0.14 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 21.64 |
| Current Ratio | 21.64 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,943.89 |
| Assets | 2,256.13 |
| Liabilities | 316.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Capital International Investors | 10.20 | 28.08 | |
| 13G/A | Nikko Asset Management Americas, Inc. | 4.24 | -15.89 | |
| 13G/A | Sumitomo Mitsui Trust Holdings, Inc. | 4.24 | -15.89 | |
| 13G/A | ARK Investment Management LLC | 10.75 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 908,625 | 2,821,026 | 32.21 | |
| 354,856 | 1,735,864 | 20.44 | |
| 351,597 | 1,723,816 | 20.40 | |
| 532,889 | 1,954,275 | 27.27 | |
| 871,557 | 3,463,407 | 25.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CMRX – Chimerix, Inc. | CRMD – CorMedix Inc. |
| CRON – Cronos Group Inc. | CRVS – Corvus Pharmaceuticals, Inc. |
| CURR – CURRENC Group Inc. |
Financial data and stock pages provided by
Fintel.io